No, today's announcement just shows that Novo Nordisk have decided not to develop the product. That doesn't mean that another pharma won't.
(I speak as someone with a fair bit of money invested for quite some time. But my view is not wishful thinking, it's carefully considered. Nevertheless, IMHO, DYOR, etc.)